News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ProMedicus.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpoint
Health & Biotech
ASX Health Stocks: Clarity’s imaging agent can identify prostate cancer lesions at double the rate
Experts
Lessons on the ASX journey from dirt bag to Ten Bag
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up as Cochlear upgrades earnings guidance
News
ASX Large Caps: ASX tumbles 1pc as mining stocks take a dip; Red5 and Silver Lake to merge
Health & Biotech
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Experts
Taking the profit on Pro Medicus? Nice one. You just broke the 1st Rule of Compounding Growth
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
Health & Biotech
ScoPo’s Powerplays: Who fancies a ‘MedWalk intervention’? Oh, and ASX healthcare stocks can’t catch a break
News
ASX Large Caps: ASX drops further on war concerns, Treasury Wine rallies on China news
Health & Biotech
ASX Health Stocks: Chimeric leaps 65pc on Phase1A results, Immutep over 12pc on Phase 2
News
CSL, Pro Medicus, Goodman Group. Which other ASX stocks have brokers upgraded?
Health & Biotech
From wine to $8.75 billion success story, Pro Medicus is embracing AI after 40 years at forefront of medical imaging
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News
ASX Large Caps: Stocks at two-month low, ProMedicus surges 11pc, and Morningstar upgrades coal stocks
News
ASX Small Caps Lunch Wrap: Which tiny town had to call the cops on the cops last week?
Health & Biotech